Nectar Life Q4 up 19.53 pc to Rs 31.82 cr
Drug firm Nectar Lifesciences said its standalone net profit rose by 19.53 per cent to Rs 31.82 crore for the quarter ended March 31, 2011.
By PTI |
NEW DELHI: Drug firm Nectar Lifesciences said its standalone net profit rose by 19.53 per cent to Rs 31.82 crore for the quarter ended March 31, 2011.
The company had posted a standalone net profit of Rs 26.62 crore in the corresponding period previous fiscal, Nectar Lifesciences said in a filing to the Bombay Stock Exchange (BSE).
Net sales of the company for the fourth quarter ended March 31, 2011 stood at Rs 338.81 crore as compared to Rs 241.66 crore for the same period last fiscal.
Standalone net profit of the company for the financial year ended March 31, 2011 stood at Rs 101.87 crore as compared to Rs 91.97 crore in the previous fiscal.
The company posted net sales of Rs 1056.22 crore for the year ended March 31, 2011 as compared to Rs 845.79 crore for the financial year ended March 31, 2010.
Shares of Nectar Lifesciences today closed at Rs 27.05 on the BSE, up 2.08 per cent from its previous close.
The company had posted a standalone net profit of Rs 26.62 crore in the corresponding period previous fiscal, Nectar Lifesciences said in a filing to the Bombay Stock Exchange (BSE).
Net sales of the company for the fourth quarter ended March 31, 2011 stood at Rs 338.81 crore as compared to Rs 241.66 crore for the same period last fiscal.
Standalone net profit of the company for the financial year ended March 31, 2011 stood at Rs 101.87 crore as compared to Rs 91.97 crore in the previous fiscal.
The company posted net sales of Rs 1056.22 crore for the year ended March 31, 2011 as compared to Rs 845.79 crore for the financial year ended March 31, 2010.
Shares of Nectar Lifesciences today closed at Rs 27.05 on the BSE, up 2.08 per cent from its previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
